ABCG2 and melanoma: In the presence of E, the efficacy of T was increased synergistically (Figure 8(c); combination index scores [52] <1 for IC30, IC50, and IC70, as shown in Supplementary Table 1) indicating the role of a CD133-ABCG2 pathway in mediating drug resistance, and adding another treatment option to melanoma therapy.